Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The objective of the proposed project is to quantify the prevalence and disparities of undiagnosed left ventricular hypertrophy (LVH) in Emergency Department (ED) patients with persistently elevated asymptomatic BP, and to measure the effect of disclosure, education, and expedited referral on 3-month outpatient follow-up and treatment rates for ED patients with newly diagnosed LVH by POCUS. Additionally, investigators will create a database of annotated clips for future development of a machine learning algorithm for LVH detection on POCUS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Two blood pressure measurements greater than 140 mmHg systolic and greater than 90 mmHg diastolic on two separate vital sign checks obtained as part of routine ED care

Locations
United States
Connecticut
Yale New Haven Hospital
RECRUITING
New Haven
Contact Information
Primary
Cristiana Baloescu, MD, MPH
cristiana.baloescu@yale.edu
(203) 737-2644
Time Frame
Start Date: 2023-10-15
Estimated Completion Date: 2025-12
Participants
Target number of participants: 200
Treatments
Experimental: Feasibility: Disclosure, customized discharge and expedited referral instructions
Participants enrolled in the Aim 1 cohort with LVH on POCUS will receive the study intervention consisting of disclosure, counseling with set discharge instructions and expedited referral (communication to existing primary care physician OR referral to follow-up clinic if no existing primary care)
Related Therapeutic Areas
Sponsors
Leads: Yale University
Collaborators: Robert E. Leet and Clara Guthrie Patterson Trust

This content was sourced from clinicaltrials.gov